Parlodel

Basic Parlodel Information

• INN (International Nonproprietary Name): Bromocriptine
• Brand Names Available In United Kingdom: Parlodel; generics such as Parlodel Sandoz and bromocriptin-ratiopharm (brands listed in European markets)
• ATC Code: G02CB01 (Bromocriptine)
• Forms & Dosages: Tablets, commonly 2.5 mg; 5 mg tablets available in some countries but not universal
• Manufacturers In United Kingdom: not specified
• Registration Status In United Kingdom: not specified
• OTC / Rx Classification: Rx only (prescription required in nearly all markets)

Critical Warnings & Restrictions

Immediate Safety Priorities For UK Patients

Is this medicine safe to start at home?

Bromocriptine (Parlodel) is a prescription-only medicine and is regulated by UK authorities such as the MHRA.

Always follow the directions given by the prescriber and the dispensing pharmacist.

Stop the medicine and seek urgent care if any of the following occur — these may indicate rare but serious cardiac, vascular or neurological events.

• Sudden, severe chest pain.
• New, sudden breathlessness or difficulty breathing.
• Fainting or sudden collapse.
• Severe, persistent vomiting.
• Sudden or severe psychiatric change (new hallucinations, severe agitation, confusion).
• Sudden weakness, numbness, or speech problems suggestive of stroke.

Report suspected adverse drug reactions to the MHRA Yellow Card scheme and inform the prescriber or pharmacist.

Absolute contraindications include uncontrolled hypertension, current or past severe psychotic disorders, known hypersensitivity to bromocriptine or other ergot alkaloids, and use in postpartum women at risk of pre-eclampsia or eclampsia.

Before starting, review the full medication list and current health problems with the prescriber and pharmacist.

• Review concurrent medicines for interactions.
• Monitor blood pressure during dose titration.
• Consider a baseline pregnancy test if relevant.
• Use supervised initiation in elderly patients or those with known cardiovascular disease.

High-Risk Groups

Who needs extra monitoring?

Elderly patients are at higher risk of orthostatic hypotension, confusion and hallucinations, especially at higher doses or when used for Parkinson’s disease.

People with established cardiac disease, hepatic or renal impairment, a history of peptic ulcer disease, or previous psychiatric illness require caution and closer follow-up.

Children should only be treated under specialist paediatric endocrine or neurology teams.

Pregnancy and breastfeeding require specialist counselling; postpartum use is contraindicated where there is pre-eclampsia or eclampsia risk.

Follow dosing-caution notes and monitoring recommendations when treating high-risk groups.

• BP monitoring frequency: baseline, after each up-titration step, and periodically once stable.
• ECG if there is significant cardiac history or symptoms.
• Liver function tests where hepatic impairment is suspected.
• Prolactin (or GH) levels according to the treating specialty protocol.

Interaction With Activities

Will Parlodel affect driving or work?

Common side effects include dizziness, fainting (syncope), visual disturbance and somnolence, particularly during dose titration.

If affected, do not drive or operate machinery until the impairment has resolved.

Under UK law, sustained or unpredictable impairment must be reported to the DVLA where applicable, and to occupational health if work safety is affected.

Employers and drivers should be informed when treatment causes persistent impairment that might affect safety-sensitive duties.

• Avoid driving during dose escalation.
• Avoid working at height while adjusting doses.
• Do not operate heavy machinery until well tolerated.

Q&A — “Can I Drive After Taking It In The UK?”

Short answer: do not drive if you feel dizzy, drowsy, faint or have visual disturbances.

During dose changes or if side effects occur avoid driving; notify the DVLA or occupational health if impairment continues.

Report adverse events to the MHRA Yellow Card scheme and inform the prescriber or pharmacist.

Usage Basics

INN, Brand Names Available In The UK

What names will my prescription show?

The International Nonproprietary Name is Bromocriptine.

In UK practice the originator trade name Parlodel is well known and generics exist from major manufacturers active in Europe.

• INN: Bromocriptine.
• Common brand names: Parlodel; generics listed in Europe include Parlodel Sandoz and bromocriptin-ratiopharm.
• Typical packaging: 2.5 mg tablets in blister packs.

Legal Classification

Do I need a prescription?

Parlodel/bromocriptine is prescription-only medicine (POM) across the UK and is subject to MHRA regulation.

NHS prescriptions are issued by GPs, hospital specialists or consultants; community pharmacists dispense and provide counselling.

Electronic prescriptions (EPS) and legitimate online pharmacies may be used, but always check the supplier is registered with the appropriate regulator.

• Who can prescribe: GP, hospital specialist, or hospital consultant.
• Dispensing safeguards: prescription verification, pharmacist counselling and advice on contraindications/interactions.
• Check MHRA-registered products and the pharmacist’s verification when using online services.

Dosing Guide

Standard Regimens

What starting dose will I be given?

Dosing is indication-specific and usually begins at a low dose with gradual titration to reduce nausea and orthostatic hypotension.

Take measures to reduce nausea — dose slowly, consider taking with food and discuss antiemetic options with the prescriber if necessary.

Adjustments For Comorbidities

Do doses change if I’m older or unwell?

Elderly patients should start at lower doses and titrate slowly because of increased risk of hypotension and central nervous system effects.

Hepatic or renal impairment requires caution with potentially lower starting doses and closer monitoring; there are no universal formal adjustment rules.

Paediatric treatment is specialist-only and dosing is managed by paediatric endocrine or neurology teams.

Pregnancy and lactation require specialist risk–benefit discussion; avoid postpartum initiation if there is pre-eclampsia/eclampsia risk.

• Checklist: start low and slow in the elderly; monitor BP at each dose increase; consider ECG if cardiac history exists.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as remembered unless it is close to the next scheduled dose.

Do not double doses to catch up.

If vomiting occurs after a dose and absorption is uncertain, contact a pharmacist or GP for advice about the next step.

Interaction Chart

Food And Drinks

Will alcohol or coffee affect it?

Alcohol can increase drowsiness and worsen orthostatic hypotension when taking bromocriptine.

Caffeine may increase jitteriness but there is no major direct interaction recorded.

Taking the tablet with food often reduces nausea; keep meals consistent during titration.

• Avoid alcohol during dose escalation or if feeling dizzy.
• Small, frequent meals can reduce nausea.
• Discuss antiemetic options with the prescriber if needed.

Common Drug Conflicts

Which medicines interact with bromocriptine?

Ask the pharmacist for a full medication review before starting, and report adverse reactions via the Yellow Card scheme to help track safety signals.

User Reports & Trends

What do patients say online?

Patient-reported experiences on NHS Choices, Patient.info and parenting forums commonly describe early nausea and dizziness during initiation, with clinical benefit for galactorrhoea and fertility related to prolactin suppression.

Many users compare tolerability to cabergoline, and report cabergoline is often better tolerated and more convenient because of less frequent dosing.

Clinically, there is a trend towards cabergoline as first-line for hyperprolactinaemia, but bromocriptine remains used where cabergoline is unsuitable or unavailable.

• Positives reported: rapid effect on galactorrhoea, effective prolactin suppression, useful when cabergoline is not an option.
• Negatives reported: early nausea, dizziness, frequent dosing and mixed tolerance compared with cabergoline.

These reports are anecdotal and should not replace specialist advice.

Access & Purchase Options

Boots, LloydsPharmacy, Superdrug

Where can patients collect Parlodel locally?

Major high-street chains dispense bromocriptine on NHS or private prescription and provide pharmacist counselling at collection.

• Bring the prescription and any repeat documentation when collecting.
• Ask the pharmacist for a medication review and interaction screening.
• Pharmacies can advise on side-effect management and monitoring schedules.

Online Pharmacies And NHS E-Prescriptions

Can it be ordered online?

Electronic Prescription Service (EPS) and legitimate online pharmacies offer convenience, but only when a valid prescription is in place.

Check that online suppliers are registered with the General Pharmaceutical Council and have an identifiable pharmacist contact.

• Verify the online pharmacy: GPhC registration, secure payment, contact details and patient reviews.
• Avoid purchasing from unregulated sellers and never use medicines without a valid prescription and clinical review.

In our online pharmacy, parlodel is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Mechanism & Pharmacology

Simplified Explanation

How does bromocriptine work?

Bromocriptine is a dopamine D2 receptor agonist and an ergot derivative that suppresses prolactin secretion from the pituitary gland.

It can also reduce growth hormone secretion in acromegaly and improve dopaminergic tone in the central nervous system for Parkinson’s adjunct therapy.

• Mechanism: Dopamine D2 receptor agonist.
• Clinical effect: Lowers prolactin, can lower GH and modestly affect glucose metabolism.
• Practical implication: Used to treat prolactin-driven amenorrhoea/galactorrhoea, as adjunct in acromegaly and Parkinson’s.

Clinical Terms

What about pharmacokinetics and monitoring?

Bromocriptine has a shorter half-life than cabergoline, which explains the need for more frequent dosing in many indications.

It is administered orally in tablet form, commonly 2.5 mg strength in blister packs.

Being an ergot class medication, rare vascular and psychiatric adverse events are possible and require vigilance.

• Monitor: blood pressure, mental state, prolactin or GH levels as per indication, and ECG if cardiac risk is present.

Indications & Off-Label Uses

MHRA-Approved Uses

What is Parlodel licensed for?

• Hyperprolactinaemia — to suppress prolactin and reverse prolactin-related symptoms.
• Parkinson’s disease — as adjunct therapy to improve motor function.
• Acromegaly — to reduce growth hormone levels as adjunctive therapy.
• Note: Cycloset (bromocriptine formulation) is approved in the USA for glycaemic control but is not a routine UK indication.

Off-Label Practices In NHS And Private Care

Are there other uses?

Off-label and research uses include investigational metabolic benefits in metabolic syndrome, cluster headache research and psychiatric research in selected contexts.

Off-label prescribing should be specialist-led, with documented informed consent and monitoring.

• Checklist for off-label use: documented rationale, informed consent, monitoring plan, specialist oversight and clear recording in clinical notes.

Key Clinical Findings

What does the recent evidence say?

Across UK and EU clinical summaries, bromocriptine is effective for prolactin suppression and symptom control in hyperprolactinaemia.

Cabergoline is often preferred for tolerability and dosing convenience, but bromocriptine remains useful in selected patients or where cabergoline is unavailable.

Safety signals have been noted for cardiovascular and psychiatric events at higher doses and in Parkinson’s contexts, emphasising individualised care and monitoring.

Regulatory surveillance continues through the MHRA Yellow Card and wider European pharmacovigilance systems.

• Takeaways: effective for prolactin suppression; dose-titration reduces side effects; monitor cardiovascular and psychiatric status at higher doses.
• Suggested references: MHRA guidance, NHS clinical summaries and specialty endocrine guidelines.

Alternatives Matrix

NHS Prescribing Alternatives

Which drugs are commonly chosen instead of Parlodel?

Choose Parlodel when cabergoline is unsuitable, when quick prolactin suppression with a tried agent is required, or when cost and availability favour bromocriptine.

Pros And Cons Checklist

• Efficacy: effective for prolactin suppression and symptomatic control.
• Side-Effect Profile: higher early nausea and orthostatic hypotension compared with cabergoline.
• Dosing Frequency: usually more frequent dosing than cabergoline.
• Pregnancy Plans: consider alternatives or specialist advice if pregnancy is planned.
• Cardiac History: weigh valvular and vascular risks and monitor accordingly.
• Cost/Access: availability and NHS formulary positions may influence choice.

Common Questions

What do patients ask most often?

• How soon will prolactin fall? — Prolactin often falls within days to weeks; levels should be monitored as instructed by the treating clinician.
• Can I stop when symptoms improve? — Only stop after clinician review and planned tapering; do not stop abruptly without medical advice.
• Is it safe during breastfeeding? — Bromocriptine is sometimes used to suppress lactation; discuss risks and benefits with obstetrician or midwife before use.
• How do I report side effects? — Report side effects to the MHRA Yellow Card scheme and inform the prescriber and pharmacist.

For further NHS guidance consult local specialist services or NHS.uk for condition-specific pathways.

NHS Cost & Access Comparison Table

The tables below outline suggested content for comparing sources and regional prescription fees — actual private prices change and should be checked with the pharmacy or NHS.

Always check current guidance on NHS.uk and verify online sellers’ GPhC registration before purchasing.

Registration & Regulation

MHRA Approval Process

How is Parlodel regulated?

The MHRA oversees product licensing, labelling and post-marketing safety for medicines supplied in the UK.

Consult the Summary of Product Characteristics (SPC), Patient Information Leaflet (PIL) and MHRA alerts for the most up-to-date guidance.

• Regulatory documents: SPC, PIL, MHRA safety updates and alerts.

NHS Prescribing Framework

Who starts treatment and who continues it?

Prescribing may be initiated by a GP, specialist or hospital team depending on indication; hospital specialists commonly initiate for acromegaly and Parkinson’s disease.

Shared-care protocols and local formularies may determine ongoing prescribing responsibilities.

• Prescriber checklist: baseline tests (BP, pregnancy status where relevant), monitoring schedule and clear shared-care agreements if required.

Storage & Handling

UK Household Storage

How should Parlodel be stored at home?

Store at room temperature and protect from excess moisture and heat.

Keep tablets in their original blister packaging until use and protect from light.

Avoid storing medicine in bathrooms or windowsills in damp UK homes; use an airtight container if humidity is a concern.

• Household tips: keep in a cool, dry place, away from children and pets.
• Travel precautions: carry in original packaging with prescription if travelling.

Guidance From NHS And Pharmacists

When should I throw it away?

Check expiry dates and return unused or expired medication to a pharmacy for safe disposal.

Do not share medication with others and store securely away from children.

• Disposal checklist: take-back to pharmacy; do not dispose in household waste.
• Transport checklist: keep at room temperature and in original packaging while travelling.

Guidelines For Proper Use

UK Pharmacist Counselling Style

What will the pharmacist tell me when dispensing?

Confirm the indication and dose, typically 2.5 mg tablets in many dispensing situations.

Review contraindications and allergies, discuss common side effects and practical management, and outline missed-dose rules.

Explain driving and workplace safety warnings and provide written information (PIL) alongside verbal advice.

• Counselling script items: indication, dose schedule, expected side effects (nausea, dizziness), when to seek urgent care, missed-dose instructions, and monitoring plan.
• Provide a patient handout summarising BP monitoring, adverse symptom red flags and Yellow Card reporting.

NHS Patient Safety Advice

What follow-up will I have on the NHS?

Pre-initiation screening should include blood pressure, psychiatric history and pregnancy status where relevant.

Suggested follow-up timeline: review at two weeks after initiation, then around three months, and thereafter as clinically indicated.

Report adverse effects to the MHRA Yellow Card scheme and keep planned medication reviews at least annually or sooner if doses change.

• Safety checklist: baseline checks, follow-up blood tests for prolactin/GH where indicated, documented monitoring plan and shared decision-making.

Delivery Across United Kingdom

Final Notes

Parlodel (bromocriptine) remains a useful, established dopamine agonist for several endocrine and neurological indications.

Prescribers should balance efficacy, side-effect profile and patient preferences when selecting between bromocriptine and alternatives such as cabergoline or quinagolide.

Patients should keep an up-to-date medication list, attend scheduled monitoring and report worrying symptoms immediately to their prescriber or via the MHRA Yellow Card scheme.

For practical supply, always use a regulated pharmacy and seek pharmacist counselling when collecting or ordering parlodel or bromocriptine tablets.